1Schwartz PJ. The long QT syndrome. Curr Prob Cardiol, 1997, 22:297 -351. 被引量：1
2Priori SG, Schwartz PJ, Napolitano C, et 81. Risk stratification in the long- QT syndrome. N Engl J Med, 2003, 348:1866- 1874. 被引量：1
3Moss AJ, Zareba W, Jackson W, et 81. Effectiveness and limitations of - blocker therapy in congenital long QT syndrome. Circulation,2000,101:616 - 623. 被引量：1
4Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype- phenotype correlation in the long QT syndrome. Circulation, 2001,103: 89- 95. 被引量：1
5Shimizu W, Tanabe Y, Aiba T,et al. Differential effects of beta- blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome. J Am CoB Cardio], 2002,39(12):1984- 1991. 被引量：1
6Shimuzu W, Antzelevitch C. Cellular basis for the ECG features of the LQT1 form of the long QT syndromeand antagonists and sodium channel repolarization and torsade de pointes effects of beta- adrenergic agonistsblokers on transmural dispersion of Circulation, 1998,98:2313 - 2322. 被引量：1
7Krahn AD,Yee R, Chauhan V, et 81. Beta blockers nonnaliza QT hysteresis in Long QT syndrome. Am Heart J, 2002,143(3):528-534. 被引量：1
7Antzelevitch C, Shimizu W. Cellular mechanisms underlying the long QT syndrome [ J ]. Curr Opin Cardiol , 2002,17:43 - 51. 被引量：1
8Huang FD, Chen J, Lin M, et al. Long-QT syndrome associated missense mutations in the pore Helix of the HERG potassium channel [J]. Circulation, 2001,104: 1071 - 1075. 被引量：1
9Schwartz PJ, Moss AV, Vincent Gm, et al. diagnostic criteria for the long QT syndrome. An update [ J ]. Circulation, 1993,88:782 - 784. 被引量：1
10Michaloudis DG, Kanakoudis FS, Xatzikraniotis A, et al. The effects of midazolam followed by administration of either vecuronium or atracurium on the QT interval in humans[ J]. Eur J Anaesthesiol 1995, 12:577 - 583. 被引量：1
